KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Retained Earnings (2016 - 2025)

Vertex Pharmaceuticals has reported Retained Earnings over the past 17 years, most recently at $13.6 billion for Q4 2025.

  • Quarterly results put Retained Earnings at $13.6 billion for Q4 2025, up 41.15% from a year ago — trailing twelve months through Dec 2025 was $13.6 billion (up 41.15% YoY), and the annual figure for FY2025 was $13.6 billion, up 41.15%.
  • Retained Earnings for Q4 2025 was $13.6 billion at Vertex Pharmaceuticals, up from -$64.5 million in the prior quarter.
  • Over the last five years, Retained Earnings for VRTX hit a ceiling of $13.6 billion in Q4 2025 and a floor of -$64.5 million in Q3 2025.
  • Median Retained Earnings over the past 5 years was $3.2 billion (2021), compared with a mean of $4.5 billion.
  • Biggest five-year swings in Retained Earnings: skyrocketed 67280.42% in 2024 and later tumbled 323.96% in 2025.
  • Vertex Pharmaceuticals' Retained Earnings stood at $15.9 million in 2021, then skyrocketed by 40923.9% to $6.5 billion in 2022, then tumbled by 100.22% to -$14.3 million in 2023, then skyrocketed by 67280.42% to $9.6 billion in 2024, then skyrocketed by 41.15% to $13.6 billion in 2025.
  • The last three reported values for Retained Earnings were $13.6 billion (Q4 2025), -$64.5 million (Q3 2025), and $11.3 billion (Q2 2025) per Business Quant data.